These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35883440)

  • 1. In Silico Discovery and Optimisation of a Novel Structural Class of Hsp90 C-Terminal Domain Inhibitors.
    Zajec Ž; Dernovšek J; Gobec M; Tomašič T
    Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel Hsp90 C-terminal domain inhibitors against Ewing sarcoma.
    Zajec Ž; Dernovšek J; Distel M; Gobec M; Tomašič T
    Bioorg Chem; 2023 Feb; 131():106311. PubMed ID: 36495678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration and optimisation of structure-activity relationships of new triazole-based C-terminal Hsp90 inhibitors towards in vivo anticancer potency.
    Dernovšek J; Zajec Ž; Poje G; Urbančič D; Sturtzel C; Goričan T; Grissenberger S; Ciura K; Woziński M; Gedgaudas M; Zubrienė A; Grdadolnik SG; Mlinarič-Raščan I; Rajić Z; Cotman AE; Zidar N; Distel M; Tomašič T
    Biomed Pharmacother; 2024 Aug; 177():116941. PubMed ID: 38889640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Novel Hsp90 C-Terminal Inhibitors Using 3D-Pharmacophores Derived from Molecular Dynamics Simulations.
    Tomašič T; Durcik M; Keegan BM; Skledar DG; Zajec Ž; Blagg BSJ; Bryant SD
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Hsp90 C-terminal domain to induce allosteric inhibition and selective client downregulation.
    Goode KM; Petrov DP; Vickman RE; Crist SA; Pascuzzi PE; Ratliff TL; Davisson VJ; Hazbun TR
    Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):1992-2006. PubMed ID: 28495207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors.
    Shao LD; Su J; Ye B; Liu JX; Zuo ZL; Li Y; Wang YY; Xia C; Zhao QS
    J Med Chem; 2017 Nov; 60(21):9053-9066. PubMed ID: 29019670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Activity Relationships of Benzothiazole-Based Hsp90 C-Terminal-Domain Inhibitors.
    Dernovšek J; Zajec Ž; Durcik M; Mašič LP; Gobec M; Zidar N; Tomašič T
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-based pharmacophore modelling, structure optimisation, and biological evaluation for the identification of 2-heteroarylthio-
    Liu Y; Li C; Li Y; Zhang S; Zhang N; Bian X; Tan S
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2290912. PubMed ID: 38083866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer.
    Zajec Ž; Dernovšek J; Cingl J; Ogris I; Gedgaudas M; Zubrienė A; Mitrović A; Golič Grdadolnik S; Gobec M; Tomašič T
    J Med Chem; 2024 Aug; 67(15):12984-13018. PubMed ID: 39042910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinazoline Based HSP90 Inhibitors: Synthesis, Modeling Study and ADME Calculations Towards Breast Cancer Targeting.
    El-Shafey HW; Gomaa RM; El-Messery SM; Goda FE
    Bioorg Med Chem Lett; 2020 Aug; 30(15):127281. PubMed ID: 32527460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel Hsp90 C-terminal domain inhibitors that disrupt co-chaperone binding.
    Mak OW; Sharma N; Reynisson J; Leung IKH
    Bioorg Med Chem Lett; 2021 Apr; 38():127857. PubMed ID: 33609661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response.
    Armstrong HK; Koay YC; Irani S; Das R; Nassar ZD; ; Selth LA; Centenera MM; McAlpine SR; Butler LM
    Prostate; 2016 Dec; 76(16):1546-1559. PubMed ID: 27526951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel anti-breast cancer agents derived from deguelin as inhibitors of heat shock protein 90 (HSP90).
    Nguyen CT; Ann J; Sahu R; Byun WS; Lee S; Nam G; Park HJ; Park S; Kim YJ; Kim JY; Seo JH; Lee J
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127374. PubMed ID: 32738983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of New Hsp90 Inhibitors: Structure Based Virtual Screening, Molecular Dynamic Simulation, Synthesis and Biological Evaluation.
    Abbasi M; Amanlou M; Aghaei M; Hassanzadeh F; Sadeghi-Aliabadi H
    Anticancer Agents Med Chem; 2021; 21(18):2583-2591. PubMed ID: 33563187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors.
    Zhao H; Garg G; Zhao J; Moroni E; Girgis A; Franco LS; Singh S; Colombo G; Blagg BS
    Eur J Med Chem; 2015 Jan; 89():442-66. PubMed ID: 25462258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 5-aryl-3-thiophen-2-yl-1H-pyrazoles as a new class of Hsp90 inhibitors in hepatocellular carcinoma.
    Mohamady S; Ismail MI; Mogheith SM; Attia YM; Taylor SD
    Bioorg Chem; 2020 Jan; 94():103433. PubMed ID: 31785857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsp90 inhibitors and drugs from fragment and virtual screening.
    Roughley S; Wright L; Brough P; Massey A; Hubbard RE
    Top Curr Chem; 2012; 317():61-82. PubMed ID: 21647838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Phenyl Cyclohexylcarboxamides as a Novel Class of Hsp90 C-terminal Inhibitors.
    Garg G; Forsberg LK; Zhao H; Blagg BSJ
    Chemistry; 2017 Nov; 23(65):16574-16585. PubMed ID: 28940589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of new Hsp90-Cdc37 protein-protein interaction inhibitors:
    Dernovšek J; Gradišek N; Zajec Ž; Urbančič D; Cingl J; Goričan T; Grdadolnik SG; Tomašič T
    RSC Adv; 2024 Sep; 14(39):28347-28375. PubMed ID: 39239280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based virtual screening and optimization of modulators targeting Hsp90-Cdc37 interaction.
    Wang L; Li L; Zhou ZH; Jiang ZY; You QD; Xu XL
    Eur J Med Chem; 2017 Aug; 136():63-73. PubMed ID: 28482218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.